USP30 p.Pro389Ser
c.1165C>T · rs147931793 · VCV3187374
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0621 | likely benign |
|---|---|---|
| REVEL | 0.042 | moderately benign-leaning |
| SaProt | LLR -6.24 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | <0.2 | no splice effect predicted · four deltas, not one · how we know |
| Constraint at this position | ||
| Conservation | phyloP -1.4 | GERP -0.59 |
| Regional constraint | o/e 0.80 | unconstrained · MANE · 33 kb · p 5.8e-07 · regional, not allelic |
| Overall | ||
| CADD | 0.215 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| East Asiangrpmax | 0.0134% | 7,466 |
| European (non-Finnish) | 0.000766% | 130,522 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- USP30
- Protein
- p.Pro389Ser
- Coding
- c.1165C>T
- MANE Select
- NM_032663
- dbSNP
- rs147931793
- Type
- single nucleotide variant
- Location
- chr12:109083059 (GRCh38)
- Gene constraint
- LOEUF 0.757 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 77.29 · 8 PDB
- Residue 389
- the usp domain; the 'disordered' region
Similar variants
- USP30 p.Ala12Val Uncertain significance ★ ⚠ same type
- USP30 p.Ala25Glu Uncertain significance ★ ⚠ same type
- USP30 p.Ala25Thr Uncertain significance ★ ⚠ same type
- USP30 p.Ala396Asp Uncertain significance ★ ⚠ same type
- USP30 p.Ala417Val Uncertain significance ★ ⚠ same type
- USP30 p.Ala494Thr Uncertain significance ★ ⚠ same type
- USP30 p.Ala6Thr Uncertain significance ★ ⚠ same type
- USP30 p.Arg105Gly Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/usp30-p-pro389ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown